Konstantinidis Ioannis T, Raoof Mustafa, Zheleva Vasilena, Lafaro Kelly, Lau Clayton, Fong Yuman, Lee Byrne
Department of Surgery, City of Hope National Cancer Center, Medical Office Building, 1500 Duarte Road, Duarte, CA, USA.
Department of Surgery, Texas Tech University Health Sciences Center, El Paso, TX, USA.
J Robot Surg. 2020 Jun;14(3):503-507. doi: 10.1007/s11701-019-01017-x. Epub 2019 Sep 6.
The application of robotic technology allows for the performance of multi-organ liver resections by multidisciplinary teams in a minimally invasive manner. Their technique and outcomes are not established. Herein we describe our technique with robotic liver surgery combined with colon, pancreas and urologic resections. Our patients are an 84-year-old (yo) female (Body Mass Index, BMI: 25) with a recently diagnosed right colon adenocarcinoma and two synchronous liver metastases at segments 5 and 6, a 75-year-old female (BMI: 50.4) with a history of right renal cell cancer status post (s/p) right robotic radical nephrectomy now with tumor recurrence with multiple intra-abdominal masses including a segment 7 liver lesion and a 71-year-old female (BMI: 24) with history of pancreatic ductal adenocarcinoma of the tail and a segment 3 liver lesion s/p neoadjuvant chemotherapy. The Xi robotic system (Intuitive Surgical, Sunnyvale, CA, USA) was utilized in all cases. Port placement in all cases was decided within the multidisciplinary teams to accommodate both the hepatic and the extra-hepatic portion of the operation. Parenchymal transections were performed with the use of the Vessel Sealer and the robotic stapler as appropriate. Indocyanine green (ICG) was used to assess the anastomotic perfusion in the first patient. Blood loss was 50 ml for the first two cases and 300 ml for the third. Surgical margins were negative in all cases. Patients were discharged at POD 8, 3 and 5 with one patient experiencing postoperative ileus. Robotic multivisceral liver resections are feasible and safe within multidisciplinary surgical teams with expertise in robotic surgery. The robotic platform can offer a minimally invasive approach in liver surgery synchronous with colonic, pancreatic and urologic surgery.
机器人技术的应用使多学科团队能够以微创方式进行多器官肝脏切除术。其技术和效果尚未确定。在此,我们描述了机器人肝脏手术联合结肠、胰腺和泌尿外科手术的技术。我们的患者包括一名84岁女性(体重指数,BMI:25),最近诊断为右结肠腺癌,在5段和6段有两个同时性肝转移灶;一名75岁女性(BMI:50.4),有右肾细胞癌病史,曾接受右机器人根治性肾切除术,现肿瘤复发,伴有多个腹腔内肿块,包括7段肝内病变;以及一名71岁女性(BMI:24),有胰尾导管腺癌病史,3段肝内病变,接受过新辅助化疗。所有病例均使用Xi机器人系统(直观外科公司,美国加利福尼亚州森尼韦尔)。所有病例的端口放置均由多学科团队决定,以适应手术的肝脏部分和肝外部分。根据情况使用血管闭合器和机器人吻合器进行实质切开。在第一例患者中使用吲哚菁绿(ICG)评估吻合口灌注。前两例患者的失血量为50毫升,第三例为300毫升。所有病例的手术切缘均为阴性。患者分别在术后第8天、第3天和第5天出院,其中一名患者出现术后肠梗阻。在具有机器人手术专业知识的多学科手术团队中,机器人多脏器肝脏切除术是可行且安全的。机器人平台可以为与结肠、胰腺和泌尿外科手术同步的肝脏手术提供微创方法。